These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 6606891)

  • 1. High incidence of neoplasms in female NZB/NZW mice treated with pulse doses of cyclophosphamide.
    Walker SE; Anver MR
    Vet Immunol Immunopathol; 1983 Nov; 5(1):97-104. PubMed ID: 6606891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerated appearance of neoplasms in female NZB/NZW mice treated with high-dose cyclophosphamide.
    Walker SE; Anver MR
    Arthritis Rheum; 1979 Dec; 22(12):1338-43. PubMed ID: 391238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulated autoantibody response and increased longevity in NZB/NZW mice treated with cyclophosphamide and tilorone.
    Walker SE; Anver MR
    Clin Exp Immunol; 1978 Sep; 33(3):453-62. PubMed ID: 737897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The course of autoimmune disease in parous NZB/NZW mice.
    Castor R; Walker SE
    J Comp Pathol; 1977 Jan; 87(1):35-42. PubMed ID: 300081
    [No Abstract]   [Full Text] [Related]  

  • 5. Prolonged lifespan and high incidence of neoplasms in NZB/NZW mice treated with hydrocortisone sodium succinate.
    Walker SE; Anver MR; Schechter SL; Bole GG
    Kidney Int; 1978 Aug; 14(2):151-7. PubMed ID: 691974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resistance to therapy in mature Palmerston North mice treated with cyclophosphamide or hydrocortisone sodium succinate.
    Walker SE; Schnitzer B
    Arthritis Rheum; 1980 May; 23(5):539-44. PubMed ID: 6966498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The oncogenic effect of immunosuppressive (cytotoxic) agents in (NZB X NZW) mice. I. Long-term treatment with azathioprine and ifosfamide.
    Mitrou PS; Fischer M; Mitrou G; Röttger P; Holtz G
    Arzneimittelforschung; 1979; 29(3):483-8. PubMed ID: 314806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective suppression of autoantibody responses in NZB/NZW mice treated with long-term cyclophosphamide.
    Walker SE; Bole GG
    Arthritis Rheum; 1975; 18(3):265-72. PubMed ID: 1095022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclophosphamide protection in NZB/NZW disease. Mechanisms and therapeutic regimens.
    Morris AD; Esterly J; Chase G; Sharp GC
    Arthritis Rheum; 1976; 19(1):49-55. PubMed ID: 130137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppressed hetergeneous antinuclear antibody response in lymphomabearing NZB/NZW mice.
    Walker SE; Bole GG
    Clin Exp Immunol; 1976 Apr; 24(1):210-7. PubMed ID: 1084817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prolonged lifespans in female NZB/NZW mice treated with the experimental immunoregulatory drug frentizole.
    Walker SE; Solsky M; Schnitzer B
    Arthritis Rheum; 1982 Nov; 25(11):1291-7. PubMed ID: 6982717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribavirin treatment in murine autoimmune disease. I. Therapeutic efficacy and effect on the immune response.
    Klassen LW; Williams GW; Reinertsen JL; Gerber NL; Steinberg AD
    Arthritis Rheum; 1979 Feb; 22(2):145-54. PubMed ID: 33680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous autoimmune disease in mouse strains other than the NZB strain.
    Zitnan D; Rovenský J; Cebecauer L; Kopecký S
    Folia Biol (Praha); 1972; 18(6):418-23. PubMed ID: 4566316
    [No Abstract]   [Full Text] [Related]  

  • 14. 1-Methylisatin 3-thiosemicarbazone treatment of NZB x NZW hybrid mice.
    Gabriel R
    Br J Exp Pathol; 1971 Jun; 52(3):271-5. PubMed ID: 5314564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceleration of glomerulonephritis in NZB x NZW mice by early immunization with DNA and injection of bacterial lipopolysaccharide. Experimental approach to the treatment of lupus nephritis by use of the accelerated model of NZB x NZW mouse disease.
    Fournie GJ; Minh MG; Mignon-Conte MA; Hass S; Lambert PH; Conte JJ
    J Clin Lab Immunol; 1980 Sep; 4(2):103-6. PubMed ID: 7441709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of nzb/nzw disease with total lymphoid irradiation.
    Kotzin BL; Strober S
    J Exp Med; 1979 Aug; 150(2):371-8. PubMed ID: 313431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The contribution of NZW genes to lupus-like disease in (NZB x NZW)F1 mice.
    Kotzin BL; Palmer E
    J Exp Med; 1987 May; 165(5):1237-51. PubMed ID: 3494806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early appearance of abnormally migrating serum IgM in control and cyclophosphamide-treated NZB/NZW mice.
    Walker SE
    J Rheumatol; 1982; 9(2):183-8. PubMed ID: 6980279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of altered prenatal hormonal environment on expression of autoimmune disease in NZB/NZW mice.
    Walker SE; Keisler LW; Caldwell CW; Kier AB; vom Saal FS
    Environ Health Perspect; 1996 Aug; 104 Suppl 4(Suppl 4):815-21. PubMed ID: 8880004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of cyclophosphamide and other immunosuppressive drugs on immune disorders and neoplasia in NZB/NZW mice.
    Hahn BH; Knotts L; Ng M; Hamilton TR
    Arthritis Rheum; 1975; 18(2):145-52. PubMed ID: 1131283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.